Literature DB >> 11003706

Human and mouse mitochondrial orthologs of bacterial ClpX.

T J Corydon1, M Wilsbech, C Jespersgaard, B S Andresen, A D Borglum, S Pedersen, L Bolund, N Gregersen, P Bross.   

Abstract

We have determined the cDNA sequence and exon/intron structure of the human CLPX gene encoding a human ortholog of the E. coli ClpX chaperone and protease subunit. The CLPX gene comprises 14 exons and encodes a 633-amino acid-long precursor polypeptide. The polypeptide contains an N-terminal putative mitochondrial transit peptide, and expression of a full-length ClpX cDNA tagged at its C-terminus (Myc-His) shows that the polypeptide is transported into mitochondria. FISH analysis localized the CLPX gene to human Chromosome (Chr) 15q22.1-22.32. This localization was refined by radiation hybrid mapping placing the CLPX gene 4.6 cR distal to D15S159. Murine ClpX cDNA was sequenced, and the mouse Clpx locus was mapped to a position between 31 and 42 cM offset from the centromere on mouse Chr 9. Experimental observations indicate the presence of a pseudogene in the mouse genome and sequence variability between mouse ClpX cDNAs from different strains. Alignment of the human and mouse ClpX amino acid sequences with ClpX sequences from other organisms shows that they display the typical modular organization of domains with one AAA(+) domain common to a large group of ATPases and several other domains conserved in ClpX orthologs linked by non-conserved sequences. Notably, a C-4 zinc finger type motif is recognized in human and mouse ClpX. This motif of so far unknown function is present only in a subset of the known ClpX sequences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003706     DOI: 10.1007/s003350010173

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  9 in total

Review 1.  The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders.

Authors:  N Gregersen; P Bross; B S Andrese; C B Pedersen; T J Corydon; L Bolund
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

2.  Active-site-directed chemical tools for profiling mitochondrial Lon protease.

Authors:  Jennifer Fishovitz; Min Li; Hilary Frase; Jason Hudak; Sandra Craig; Kristin Ko; Anthony J Berdis; Carolyn K Suzuki; Irene Lee
Journal:  ACS Chem Biol       Date:  2011-05-06       Impact factor: 5.100

Review 3.  Mitochondrial AAA proteases: A stairway to degradation.

Authors:  Tyler E Steele; Steven E Glynn
Journal:  Mitochondrion       Date:  2019-08-01       Impact factor: 4.160

4.  Mitochondrial ClpP activity is required for cisplatin resistance in human cells.

Authors:  Yang Zhang; Michael R Maurizi
Journal:  Biochim Biophys Acta       Date:  2015-12-07

Review 5.  Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential.

Authors:  Heike Brötz-Oesterhelt; Andreas Vorbach
Journal:  Front Mol Biosci       Date:  2021-05-13

Review 6.  Mitochondrial ATP-Dependent Proteases-Biological Function and Potential Anti-Cancer Targets.

Authors:  Yue Feng; Kazem Nouri; Aaron D Schimmer
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 7.  Multifunctional Mitochondrial AAA Proteases.

Authors:  Steven E Glynn
Journal:  Front Mol Biosci       Date:  2017-05-22

8.  Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors.

Authors:  Suzana Gispert; Dajana Parganlija; Michael Klinkenberg; Stefan Dröse; Ilka Wittig; Michel Mittelbronn; Pawel Grzmil; Sebastian Koob; Andrea Hamann; Michael Walter; Finja Büchel; Thure Adler; Martin Hrabé de Angelis; Dirk H Busch; Andreas Zell; Andreas S Reichert; Ulrich Brandt; Heinz D Osiewacz; Marina Jendrach; Georg Auburger
Journal:  Hum Mol Genet       Date:  2013-07-12       Impact factor: 6.150

Review 9.  Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy.

Authors:  Kazem Nouri; Yue Feng; Aaron D Schimmer
Journal:  Cell Death Dis       Date:  2020-10-09       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.